The WCO and CooperVision partner to define and promote a standard of care to treat myopia progression.

Myopia causes light rays to focus at a point in front of the retina rather than directly on the surface. It is projected to affect the vision of approximately five billion people globally by 2050, more than doubling today’s numbers.1

Myopic progression has been linked to sight-threatening conditions later in life such as cataracts, retinal detachment, glaucoma and myopic maculopathy.2

The joint initiative’s standard of care definition and promotion will be centered around evidenced-based approaches without bias toward any particular treatment methodologies.

In many cases, the latest resources related to the early intervention, control and correction of myopia have not been widely accessible or actively addressed in certain sectors and countries.

The partnership between WCO and CooperVision will establish a global resource to include multi-lingual myopia management resources and programming, among other elements that will be separately announced in the coming months. 

 “The World Council of Optometry and CooperVision share a vision of a planet where myopia is effectively managed and controlled, not just corrected at a young age,” said Gary Orsborn, OD, vice president of Global Professional, Medical & Clinical Affairs for CooperVision.

“The WCO has a clear, resounding and respected voice within the global optometric community, and we are thrilled to partner with them on this important topic.”


 1 Holden et al, – Global Prevalence of myopia and high myopia and temporal trends from 2000 through 2050. Ophthalmology 2016. 123(5):1036-1042

 2 Flitcroft DI. The complex interactions of retinal, optical and environmental factors in myopia aetiology. Prog Retin Eye Res. 2012;31:622-60.